Skip to main content

Table 4 The association between NDC80 and LUAD clinical pathological features

From: Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development

parameters NDC80 P value
+
Gender P = 0.209
 male 45 (45.9%) 53 (54.1%)
 female 68 (54.4%) 57 (45.6%)
Age P = 0.027
  <  60 years old 24 (39.3%) 37 (60.7%)
  ≥ 60 years old 82 (56.2%) 64 (43.8%)
Smoke P = 0.002
 no 23 (65.7%) 12 (34.3%)
 Current smoker 15 (32.6%) 31 (67.4%)
 Smoker < 15 years 31 (44.9%) 38 (55.1%)
 Smoker ≥15 years 39 (59.1%) 27 (40.9%)
Stage P = 0.032
 I 66 (57.4%) 49 (42.6%)
 II 23 (48.9%) 24 (51.1%)
 III 15 (31.9%) 32 (68.2%)
 IV 5 (55.6%) 4 (44.4%)
T P = 0.199
 I 37 (61.7%) 23 (38.3%)
 II 63 (47.7%) 68 (52.3%)
 III 7 (41.2%) 10 (58.8%)
 IV 6 (40.0%) 9 (60.0%)
N P = 0.053
 - 69 (56.6%) 53 (43.4%)
 + 44 (43.6%) 57 (56.4%)
M P = 0.497
 - 81 (50.9%) 78 (49.1%)
 + 27 (45.8%) 31 (54.2%)